statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

STAMFORD, Conn., April 04, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results...

GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024

In a report released today, Daniel Brennan from TD Cowen maintained a Buy rating on GeneDx Holdings (WGS Research Report), with a price target of...

GeneDx Holdings (WGS) Gets a Buy from TD Cowen

In recent trading, shares of GeneDx Holdings Corp (WGS) have crossed above the average analyst 12-month target price of 9.12, changing hands for 9.46/share. When a stock reaches the target...

WGS Crosses Above Average Analyst Target

This indicator may be signaling that WGS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

GeneDx Holdings (WGS, $8.42) entered Downtrend as Momentum indicator drops below 0 level on Mar 19, 2024

STAMFORD, Conn., March 14, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced its scientific contributions at...

GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics

STAMFORD, Conn., Feb. 26, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced that company...

GeneDx to Participate in 44th Annual Cowen Health Care Conference

In recent trading, shares of GeneDx Holdings Corp (WGS) have crossed above the average analyst 12-month target price of 7.38, changing hands for 8.21/share. When a stock reaches the target...

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GeneDx Holdings (WGS Research Report) and Glaukos...

Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS) and Glaukos (GKOS)

Full Year 2024 Revenue Guidance Set Between $220M and $230MRelated Stocks: WGS...

GeneDx Holdings Corp (WGS) Reports Strong Revenue Growth and Margin Expansion in Q4 2023

GeneDx Holdings Corp. 2023 Q4 - Results - Earnings Call Presentation...

GeneDx Holdings Corp. 2023 Q4 - Results - Earnings Call Presentation

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

Volume	716,820.00
52-Wk High	$21.71
52-Wk Low	$1.16

WGS GeneDx Holdings Corp - Ordinary Shares - Class A

About

Feed

News

Sentiment

Earnings

Fundamentals